Learn why “Demographic Guides” is not a mass tort and which case details must be verified before pursuing a claim.
Verify the correct PFAS docket, understand the newest filings, and avoid mistaking allegations or proposed relief for compensation.
Track the latest talc, PFAS, hernia-device, and port-case developments—and the deadlines that may affect claims.
Learn which facts can be proved for a whole class and which injury records remain personal to each claimant.
Understand the latest mass-arbitration data, procedural risks, court limits, and practical checks for coordinated claims.
August’s MDL developments include a new PFAS docket, a Depo-Provera program, and important transfer limits.
Track the Depo-Provera deadline, separate GLP-1 injury dockets, and the participation hurdle facing the J&J talc plan.
Learn how mass-tort screening tools affect proof, human review, and the questions claimants should ask before relying on a result.
Track the changed MDL mix, proof barriers, aging dockets, and the September 24 centralization hearing.
Track the settlement conditions, evidence disputes, and MDL decisions shaping major defendant exposure after August 3.